Finance

Lists
Why is 688166 down 2.22%?
Dive Deeper
688166:SHA
BrightGene Bio-Medical Technology Co Ltd
CN¥30.85
-2.22%
(-0.70) 1D
Oct 15, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688166...
Open
CN¥31.18
High
CN¥32.49
Low
CN¥30.71
Mkt. cap
13.53B
Avg. vol.
9.75M
Volume
9.09M
Dividend
0.05%
Quarterly dividend
CN¥0.00
Ex-dividend date
Jun 9, 2026
P/E ratio
127.51
52-wk high
CN¥72.88
52-wk low
CN¥28.74
EPS
CN¥0.24
No. of employees
1K
Open
CN¥31.18
High
CN¥32.49
Low
CN¥30.71
Mkt. cap
13.53B
Avg. vol.
9.75M
Volume
9.09M
Dividend
0.05%
Quarterly dividend
CN¥0.00
Ex-dividend date
Jun 9, 2026
P/E ratio
127.51
52-wk high
CN¥72.88
52-wk low
CN¥28.74
EPS
CN¥0.24
No. of employees
1K
News stories
From web sources and news partners
About BrightGene Bio-Medical Technology Co Ltd
CEO-
Employees1.2K
FoundedOct 26, 2001
Headquarters-
SectorPharmaceutical industry
Websitebright-gene.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
336.81M
349.39M
324.93M
353.16M
Cost of goods sold
146.49M
190.48M
140.46M
166.46M
Cost of revenue
146.49M
190.48M
140.46M
166.46M
Research and development expenses
78.14M
88.52M
120.15M
50.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64.94M
57.21M
44.04M
44.48M
Operating expense
143.79M
168.94M
172.93M
112.10M
Total operating expenses
290.29M
359.43M
313.39M
278.56M
Operating income
46.52M
-10.03M
11.54M
74.61M
Other non operating income
7.34M
-8.39M
-2.77M
2.74M
EBT including unusual items
27.44M
-8.51M
-3.48M
64.48M
EBT excluding unusual items
33.06M
-29.33M
-9.49M
51.13M
Income tax expense
-2.29M
-14.07M
-12.98M
9.49M
Effective tax rate
-8.36%
165.46%
373.27%
14.73%
Other operating expenses
-547.06K
395.69K
76.94K
2.22M
Net income
33.15M
4.19M
9.29M
49.64M
Net profit margin
9.84%
1.20%
2.86%
14.06%
Earnings per share
-
-
-
-
Interest and investment income
4.99M
-
311.49K
1.05M
Interest expense
-19.34M
-17.00M
-18.58M
-20.07M
Net interest expenses
-14.35M
-17.00M
-18.27M
-19.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
70.48M
25.86M
47.44M
113.59M
Gain or loss from assets sale
-
-
-
-8.82K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps